Applied DNA to Participate in Maxim Group’s COVID-19 Virtual Conference Series on May 27
May 21st, 2020
Tag: Investor
Applied DNA Reports 2020 Fiscal Second Quarter Financial Results
May 14th, 2020
Applied DNA Schedules Fiscal 2020 Second Quarter Financial Results Conference Call for Thursday, May 14, 2020 at 4:30 PM ET
May 7th, 2020
Applied DNA Receives Approximately $5.3 Million in Net Proceeds from Warrant Exercise
May 6th, 2020
Applied DNA to Speak on COVID-19 Panel at Maxim Group’s Infectious Disease Virtual Conference on May 5
April 14th, 2020
Applied DNA Reports FY’20 Q1 Results
February 6th, 2020
APDN Schedules FY’20 Q1 Financial Results Conference Call
January 30th, 2020
Applied DNA to Hold Investment Community Meetings During the JP Morgan 38th Annual Healthcare Conference and Present at the Biotech Showcase 2020
January 10th, 2020
Colorcon, Inc. Launches On-Dose Authentication Platform From Applied DNA Sciences
December 23rd, 2019